Skip to main content
Clinical Trials/NCT06089811
NCT06089811
Recruiting
Not Applicable

A Nutritional Intervention to Prevent Stress Induced Intestinal Hyper-Permeability

KU Leuven1 site in 1 country48 target enrollmentOctober 10, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stress, Psychological
Sponsor
KU Leuven
Enrollment
48
Locations
1
Primary Endpoint
Executive functions during a prolonged stress task (the Leuven Prolonged Stress Test)
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The interaction between the gut microbiome, the intestinal barrier, and the host plays an important role in human health. The integrity of the intestinal barrier is essential to protect against translocation of food antigens and immunostimulatory microbial metabolites from the gut lumen. Accumulating studies show that stress may negatively affect the intestinal barrier function. In a previous study, the investigators developed the Leuven Prolonged Acute Stress Test (L-PAST), which combines physical (cold water), mental (arithmetic), and social (negative feedback) aspects of stress for a prolonged (2h) time. In the current study the investigators would like, as a first aim, to investigate whether the L-PAST 1) increases intestinal permeability compared to baseline intestinal permeability, and 2) whether a nutritional intervention can improve baseline intestinal permeability as well as intestinal permeability after exposure to the L-PAST in both healthy females and men. As a second aim of the present study, the investigators would like to investigate whether prebiotics and/or L-tryptophan can attenuate the cortisol response to stress. Lastly, as acute psychosocial stress impairs cognitive functions, the investigators would like as a third aim to investigate whether prebiotics and/or L-tryptophan supplementation may prevent these impairments.

Registry
clinicaltrials.gov
Start Date
October 10, 2023
End Date
July 1, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
KU Leuven
Responsible Party
Principal Investigator
Principal Investigator

Kristin Verbeke

Prof.

KU Leuven

Eligibility Criteria

Inclusion Criteria

  • Age 18 till 40 years (both included)
  • BMI range: 18.5 - 25 kg/m²
  • Females: Use of contraceptives, and have to use the current contraceptive method for at least 4 months. A regular menstrual cycle (between 25 and 35 days; if not using oral contraceptives)
  • Subject is willing to not consume caffeine, or alcohol, to refrain from smoking, and not to engage in heavy physical exercise three days before the test days, as well as to not consume dairy products and chewing gum the day before and the day of the test days
  • Subject is willing to not take any non-steroidal anti-inflammatory drugs (NSAIDs) two weeks before the test days (see Appendix G for an overview of NSAIDs)
  • Subject, upon briefing of the content of the present study, fully understands and agrees to its objective and has given written (dated and signed) informed consent form to take part in the study
  • Subject is able to communicate well with the investigator and follow instructions given by the investigator

Exclusion Criteria

  • Subject has a previous or current neurological, psychiatric, gastrointestinal, or endocrine disorder, or other relevant medical history
  • Subject has one or more diagnoses based on the MINI international neuropsychiatric interview
  • Subject has one or more diagnoses based on the ROME-IV for GI disorders
  • Subject uses regular medication (i.e., anti-allergy medication, PPI's, and medication that can affect gut motility), currently or recently (in the last 2 weeks) (except for oral contraceptives)
  • Subject has used recreational drugs in the past 6 months
  • Subject consumes regularly (\>1/week) more than 3 units of alcohol per day
  • Subjects smokes \>7 cigarettes per week
  • Subject has to work in night-shifts
  • Subject is pregnant or lactating
  • Subject has previous experience with the stress test used in the study

Outcomes

Primary Outcomes

Executive functions during a prolonged stress task (the Leuven Prolonged Stress Test)

Time Frame: Measured during the stress induction task during both the pre-intervention visit and immediately after the 4 week intervention.

Working memory, cognitive flexibility, and response inhibition. Working memory will be assessed using the forward digit span. Cognitive flexibility will be assessed using the Wisconsin Card Sorting Test. Response inhibition will be assessed using the Stop Signal Task.

Secondary Outcomes

  • Intestinal permeability after a prolonged stress task (the Leuven Prolonged Stress Test)(Measured at the pre-intervention and immediately after the 4 week intervention.)
  • Stress response to a prolonged stress test (the Leuven Prolonged Stress Test)(During the stress task (at multiple time points during 120 min), measured at the pre-intervention and immediately after the 4 week intervention.)

Study Sites (1)

Loading locations...

Similar Trials